Abstract
Objectives
To investigate the long-term effects of non-pharmacological interventions (NPIs) measures on the epidemiological characteristics of common respiratory viruses in preschool children in Henan, China.
Methods
This was a retrospective observational study containing data from 17 prefecture-level cities in Henan, China. We analyzed and compared laboratory results and clinical data of preschool children presenting to outpatient clinics for acute respiratory infections (ARTI) after COVID-19 (January 2020–October 2022) and before COVID-19 (December 2017–December 2019). Each year was divided into quarters. The ratio of the odds ratios (ORs) of testing positive for eight respiratory viruses in each year after the pandemic to the prepandemic period was estimated applying a generalized linear model (GLM), using the mean of the positive detection rates in 2018–2019 as a reference.
Results
A total of 11,400 children were enrolled from December 2017 to October 2022. The number of positive detections for all respiratory viruses decreased in 2020–2022 compared to the average of 2018–2019. Human respiratory syncytial virus (hRSV), human rhinovirus (hRV), and influenza virus (IFV) accounted for a larger proportion of all detected viruses before COVID-19 pandemic, whereas hRV, human bocavirus (hBoV), and human adenovirus (hAdV) accounted for a significantly larger proportion after COVID-19 pandemic. The positive detection rates of enveloped viruses [IFV, human parainfluenza virus (hPIV), hRSV, human metapneumovirus (hMPV), and human coronavirus (hCoV)] decreased sharply and the seasonal activity of these viruses was weakened, while the positive detection rates of non-enveloped viruses (hRV, hBoV, and hAdV) increased, especially hRV. The conditions described above tended to occur more frequently in boys and children older than 1 year, and they were also more sensitive to the NPIs.
Conclusions
NPIs transformed the epidemiological profile of common respiratory viruses among preschool children during the COVID-19 pandemic. To improve the overall public health response to all respiratory viruses, interventions targeting non-enveloped viruses need to be strengthened to mitigate their continued transmission.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
1 Introduction
Respiratory viral infections, caused by dozens of various types of viruses, represent the most common cause of childhood morbidity and mortality as well as a global health concern [1,2,3]. Viruses had been reported to account for up to 90% of the causes of pneumonia in infants under 1 year old and about 50% in preschool children [4]. The common viruses causing ARTI in children include viruses with an envelope structure, such as IFV, hPIV, hRSV, hMPV, and hCoV, as well as viruses without envelope structure, including hRV, hBoV, and hAdV [5]. Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in 2020, NPIs, including social distancing, wearing masks, hand hygiene, limiting crowd gathering, and restricting outdoor activities, had been implemented worldwide to control the spread of COVID-19. Some studies had shown that these measures also altered the prevalence of other respiratory viral infections in adults and children, but these findings were inconsistent [6,7,8,9,10]. In contrast, there remains a lack of systematic studies on whether and how NPIs affect other respiratory pathogens in preschool children, one of the vulnerable groups. Hence, analysis of the distribution and epidemiological changes of respiratory viruses in preschool children before and after the COVID-19 pandemic is essential for the prevention and control of respiratory infections in children.
We conducted a retrospective study of the results of eight respiratory viruses commonly detected in preschool children (under 7 years of age) in Henan Province, China. We analyzed the respiratory virus data of the last 5 years (December 2017–October 2022) to obtain the changes on the number of positives, positivity rates, population gender, age, virus type, and epidemic season in various respiratory virus before and after the epidemic to better understand the impact of COVID-19 pandemic and NPIs on respiratory virus infections in children.
2 Methods
2.1 Study Design
We obtained the data from the Children's Hospital Affiliated to Zhengzhou University, a tertiary‐level children's health care institution integrating medical care, health care, public health, teaching, research, and training, and one of the largest children's specialty hospitals in Henan Province, central China. The children participating in the study were all from 17 prefecture-level cities in Henan Province, and all had lived there for more than 6 months.
In this study, we randomly selected preschool children who were seen in outpatient clinics for ARTI from December 2017 to October 2022 as study subjects. According to the Centers for Disease Control and Prevention(CDC) criteria, enrolled children met the following criteria: (i) children aged younger than 7 years, regardless of gender; (ii) confirmed fever (temperature > 37.5 °C); (iii) one or more respiratory symptoms and/or signs within 14 days of onset [cough, sore throat, sputum, shortness of breath, lung auscultation abnormality (rale or wheeze), tachypnea, and chest pain] [11]; (iv) complete pathogenetic test data were available for each specimen. The exclusion criteria for this study were (i) children with nonviral respiratory infections; (ii) children with recurrent visits within 1 week; (iii) children with hospital-acquired infections; (iv) children with congenital pulmonary airway malformations and compromised immune systems; (v) children infected with COVID-19.
Study subjects were grouped: (i) by year; (ii) by gender; (iii) by age, that was, infancy (≤ 1 year), early childhood (1 to 3 years), and preschool (3 to 7 years). The study was approved by the Ethics Committee of Children's Hospital Affiliated to Zhengzhou University. This retrospective study did not involve any personal private information of the patients and only statistical analysis of the available test data was performed. The committee waived the need for individual informed consent.
2.2 Data Collection and Specimen Detection
We obtained the demographic information of enrolled children from their electronic medical records. Respiratory specimens (including nasal swabs, pharyngeal swabs, nasopharyngeal aspirates or sputum, and bronchoalveolar lavage fluid) were obtained from all enrolled children immediately after admission by trained staff following standard operating procedures. And the specimens were immediately (within 12 h) transferred to the clinical laboratory for respiratory virus testing via sterile virus transfer media (Beijing Yongkang Biotechnology Co., Ltd., China). The respiratory specimens were kept at a temperature of 2–8 °C at all times during preservation and transportation for testing.
Upon arrival at the laboratory, clinical specimens were processed in a Class II biosafety cabinet. The supernatant was then centrifuged to obtain a supernatant for screening of multiple respiratory pathogens. The total nucleic acids of each specimen were extracted using EasyPure Viral DNA/RNA Kit (TransGen Biotech, Beijing, China) in accordance with the manufacturer's instructions. IFV, hPIV, hRSV, hMPV, hCoV, and hRV were detected by RT-PCR, and hAdV and hBoV were tested by PCR according to the standard operating protocol (SOP) of surveillance developed by China CDC. If either of the target viruses was detected in the sample, the patient was considered positive for that virus. In cases where two viruses were detected in the same clinical sample, the respective viruses were counted separately.
2.3 Statistical Analysis
The number of positive infections for each respiratory virus in different years and seasons was expressed as an absolute number, and the positive detection rate was expressed as a percentage. We plotted the time-series changes of eight respiratory viruses during 2018–2022, describing the changes in the number of positive respiratory virus infections, positive detection rates, and virus distribution in children across years and seasons. A Chi-square test or Fisher's exact test was used to compare the differences in the positive rates of various viruses before the COVID-19 pandemic (2018–2019) and after the COVID-19 pandemic (2020–2022) (using the mean of virus positivity rates in 2018–2019 compared with the mean of 2020–2022). The ratio of the odds ratios (ORs) of testing positive for eight respiratory viruses in each year after the pandemic (2020–2022) to the pre-pandemic period 2018–2019 was estimated applying a generalized linear model (GLM), using the mean of the positive detection rates in 2018–2019 as a reference. Relevant confounding factors were also controlled for, including child gender, age, health status, and residence; parental age, education level, occupation, and monthly household income. Analysis was also performed by gender and different age groups. When analyzing by gender stratification, no adjustment was made for the child's gender; when analyzing by age group stratification, no adjustment was made for the child's age. Statistical significance was evaluated with two-sided p values at the level of α = 5%. All statistical analyses were conducted in the IBM SPSS Statistics for Windows (version 27.0.; IBM Corp.) and R software (version 4.0.3, R Development Core Team 2020).
3 Results
3.1 Clinical Characteristics of Included Children
A total of 11,400 children with respiratory infections were included in this study. Overall, 5774 (50.6%) of the 11,400 specimens tested positive for at least one of the eight viruses, and the virus detection rate increased after the epidemic, with statistically significant differences in virus detection rates between years (P < 0.001) (Table 1).
3.2 Comparison of Respiratory Virus Positivity Rates by Year
We investigated eight respiratory viruses (IFV, hPIV, hRSV, hMPV, hCoV, hRV, hBoV, and hAdV) in children with respiratory infections. As shown in Fig. 1, the mean detection rate of IFV was 7.77% in 2018–2019, which was higher than in 2020–2022 (3.13%) after the COVID-19 epidemic, with a statistically significant difference (P < 0.001). The positive detection rate of hPIV showed a decreasing trend year by year, and the mean detection rate of hPIV was higher between 2018 and 2019 (3.10%) than between 2020 and 2022 (1.77%), with a statistically significant difference (P < 0.001). The mean detection rate of hRSV was higher between 2018 and 2019 (7.34%) than between 2020 and 2022 (2.57%), with a statistically significant difference (P < 0.001). The mean detection rate for hMPV was 3.35% in 2018–2019, which was higher than in 2020–2022 (1.04%), with a statistically significant difference (P < 0.001). The mean detection rate for hCoV was higher between 2018 and 2019 (2.83%) than between 2020 and 2022 (0.97%), with a statistically significant difference (P < 0.001).
Changes in the positive rates of eight respiratory viruses in preschool children from 2018 to 2022 in Henan, China. A Trends in eight respiratory viruses positivity from 2018 to 2022 in Henan, China; B comparison of the positive rates of eight respiratory viruses before and after the COVID-19 pandemic in Henan, China. ***The P value is less than 0.001
In addition, the mean detection rate of hRV was 16.27% in 2018–2019, which was lower than in 2020–2022 (33.68%) after the COVID-19 epidemic, with a statistically significant difference (P < 0.001). The mean detection rate for hBoV was lower between 2018 and 2019 (4.45%) than between 2020 and 2022 (7.22%), with a statistically significant difference (P < 0.001). The mean detection rate of hAdV was slightly lower between 2018 and 2019 (4.13%) than between 2020 and 2022 (4.48%), with no statistically significant difference (P = 0.537) (Fig. 1).
3.3 Changes in the Epidemic Season of Respiratory Virus
The results showed a reduction in the number of positive infections for each virus in 2020–2022 compared to 2018 and 2019, with the least in 2020. The positive detection rates of IFV, hPIV, hRSV, hMPV, and hCoV showed a decreasing trend, while the positive detection rates of hBoV and hAdV did not decrease and the positive detection rate of hRV increased. In addition, all respiratory virus infections in preschool children were distinctly seasonal before the COVID-19 pandemic, with IFV, hPIV, and hRSV infections prevalent in spring, hRV and hBoV infections in summer and fall, and IFV, hRSV, hMPV, hCoV, and hAdV infections in winter, whereas the seasonality of viral infections was diluted during the COVID-19 pandemic (Fig. 2).
3.4 Changes in the Proportion of Respiratory Viruses
Further, we analyzed the distribution of respiratory viruses among preschool children before and after the COVID-19 pandemic. The results revealed an unusual change in the proportion of respiratory viruses detected since the COVID-19 outbreak. The detection rates and distribution of respiratory viruses were affected by COVID-19 pandemic, and after the first wave of the COVID-19 outbreak (after January 2020), although only few enveloped viruses (IFV, hPIV, hRSV, hMPV, and hCoV) were detected, more non-enveloped viruses (hRV, hBoV, hAdV) were still detected in children. There was also some variation in the proportion of viruses. hRSV, hRV, and IFV accounted for a larger proportion of all detected viruses before COVID-19 pandemic, whereas hRV, hBoV, and hAdV accounted for a significantly larger proportion after COVID-19 pandemic (Fig. 3).
3.5 Effects of NPIs on Activity of Respiratory Viruses
The pattern of the phase-specific ORs (Table 2) was further revealed largely consistent with that of the percentage changes in Figs. 1 and 2, with some subtle differences. Without stratification, the ORs of enveloped viruses (IFPV, hPIV, hRSV, hMPV, and hCoV) were less than 1 in 2020, 2021, and 2022, and the implementation of NPIs reduced the positive detection rates of these viruses. The ORs of non-enveloped viruses (hRV, hBoV, and hAdV) were all greater than 1, and NPIs had little protective effect on these viruses, especially hRV. After stratification by gender, the same effect was still observed in boys, and only the ORs of both hRSV and hRV were statistically significant over 3 years in girls, with diminished hRSV activity and enhanced hRV activity. After stratification by age group, it was still observed that the ORs of IFV, hPIV, hRSV, hMPV, and hCoV were all less than 1 and the ORs of hRV, hBoV, and hAdV were all greater than 1 in each age group after the COVID-19 epidemic due to the implementation of NPIs measures. Most of these ORs were statistically significant in children older than 1 year, whereas these effects were not significant in children younger than 1 year.
4 Discussion
In this study, we retrospectively assessed the positive detection rates for eight respiratory viruses commonly seen in children with ARTI attending before and after the COVID-19 epidemic. The overall positive detection rate was 48.4% in 2018, 50.0% in 2019, 60.1% in 2020, 55.3% in 2021, and 50.9% in 2022, which was lower than the positive detection results reported in the other studies (62.4 ~ 85.2%) [12,13,14,15]. The number of specimens tested in 2020–2022 decreased compared with 2018–2019, but the overall positive rate increased, probably because the series of NPIs against SARS-CoV-2 also effectively stopped the transmission of other respiratory viruses. However, these measures had increased the resistance to visit the hospital, and only those children with more severe symptoms and signs tended to come to the hospital. Therefore, the number of infections decreased without a decrease in positive detection rates.
Our results demonstrated that NPIs seemed to be more effective against enveloped viruses, such as IFV, hPIV, hRSV, hMPV, and hCoV than non-enveloped viruses, such as hRV, hBoV, and hAdV. And these NPIs measures did not even have any effect on reducing the transmission of non-enveloped viruses, which was also consistent with the results of some studies [16,17,18]. This may be mainly attributed to the superior thermal properties of non-enveloped viruses, their ability to tolerate dry and acidic environments, and their relatively low sensitivity to alcohol, which allows them to survive longer in external environments and remains active and infectious under unfavorable conditions [19, 20]. Previous studies have shown that masks offer less protection against hRV infection than against IFV or hCoV [21, 22]. However, our findings indicated that NPIs’ measures against SARS-CoV-2 could not eliminate not only hRV but also non-enveloped viruses, such as hBoV and hAdV.
Our data also revealed that infants under 3 years old were more susceptible to respiratory viral infections than children 3–7 years old, mainly due to physiological differences in the respiratory tract and immaturity of the immune system [23, 24]. And infants under 3 years old performed worse on NPIs measures than older children, so the study data presented that infants were less sensitive to the protective effect of NPIs measures. In terms of gender, our study found that boys were more susceptible to respiratory viruses and more sensitive to the protective effects of NPIs measures. Probably mainly because boys preferred outdoor activities and socialization compared to girls [25, 26], and the implementation of NPIs measures reduced these activities. Further studies were also required to fully elucidate the mechanisms of sexual differences in respiratory viral infections.
There were also some limitations in our study: a causal relationship between viral activity and NPIs measures could not be inferred from the data obtained. Our analysis was based on the rate of positive tests, for which changes in health care delivery practices had little effect on the results, but it still could not be excluded that the pandemic had changed the profile of children seeking medical assistance for ARTI. Finally, we conducted this study at a single institution. Nevertheless, the institution where the specimens were collected was the core pediatric hospital in the region. Therefore, it is considered to be a strong reflection of the prevalence of respiratory viruses in preschool children in the region and the results obtained are of some informative value.
5 Conclusion
In conclusion, NPIs altered the proportion of respiratory viruses detected in preschool children and diminished the rates of infection with enveloped viruses but not with non-enveloped viruses during the COVID-19 pandemic. To improve the global public health response to all respiratory transmitted viruses, interventions targeting non-enveloped viruses need to be strengthened to mitigate their continued transmission. The educational aims of this study are to have informed clinical healthcare professionals about the impact of NPIs on the pattern of respiratory viral infections in children, and to provide basic research data for the integration of resources in healthcare organizations after the epidemic. It also provides theoretical basis and practical reference for guardians on how to prevent respiratory viral infections in preschool children. In addition, future research directions should consider how the epidemiologic characteristics of respiratory viral infections in preschool children change after the elimination of NPIs, and whether enveloped viral infections will make a comeback. And continuous and dynamic surveillance of respiratory data will help prevent major outbreaks of respiratory viral infections after the epidemic.
Availability of Data and Materials
The data included in this study were collected by the researchers and were in principle not publicly available unless specifically needed.
Abbreviations
- NPIs:
-
Non-pharmacological interventions
- ARTI:
-
Acute respiratory infections
- ORs:
-
Odds ratios
- GLM:
-
Generalized linear model
- IFV:
-
Influenza virus
- hPIV:
-
Human parainfluenza virus
- hRSV:
-
Human respiratory syncytial virus
- hMPV:
-
Human metapneumo virus
- hCoV:
-
Human coronavirus
- hRV:
-
Human rhinovirus
- hBoV:
-
Human bocavirus
- hAdV:
-
Human adenovirus
- SARS-CoV-2:
-
Severe acute respiratory syndrome coronavirus 2
- CDC:
-
Centers for Disease Control and Prevention
- SOP:
-
Standard operating protocol
- CI:
-
Confidence interval
References
Kloepfer KM, Kennedy JL. Childhood respiratory viral infections and the microbiome [J]. J Allergy Clin Immunol. 2023;152(4):827–34.
Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, Lawn JE, Cousens S, Mathers C, Black RE. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals [J]. Lancet (London, England). 2016;388(10063):3027–35.
Cai XY, Wang Q, Lin GY, Cai ZW, Lin CX, Chen PZ, Zhou XH, Xie JC, Lu XD. Respiratory virus infections among children in South China [J]. J Med Virol. 2014;86(7):1249–55.
Zhu G, Xu D, Zhang Y, Wang T, Zhang L, Gu W, Shen M. Epidemiological characteristics of four common respiratory viral infections in children [J]. Virol J. 2021;18(1):10.
Doan Q, Enarson P, Kissoon N, Klassen TP, Johnson DW. Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department [J]. Cochrane Database Syst Rev. 2014;2014(9):6452.
Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, Nesdale A, Dowell T, Turner N, Campbell-Stokes P, et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand [J]. Nat Commun. 2021;12(1):1001.
Nguyen QT, Dao TL, Pham TD, Tran TK, Hoang VT, Gautret P. Effect of the COVID-19 Outbreak on the Incidence of Other Respiratory and Gastrointestinal Infections in Children in Thai Binh, Vietnam in 2020 [J]. J Epidemiol Global Health. 2022;12(2):182–7.
Li ZJ, Yu LJ, Zhang HY, Shan CX, Lu QB, Zhang XA, Ren X, Zhang CH, Wang YF, Lin SH, et al. Broad Impacts of Coronavirus Disease 2019 (COVID-19) Pandemic on Acute Respiratory Infections in China: An Observational Study [J]. Clin Infect Dis. 2022;75(1):e1054–62.
Kuitunen I, Artama M, Haapanen M, Renko M. Rhinovirus spread in children during the COVID-19 pandemic despite social restrictions-A nationwide register study in Finland [J]. J Med Virol. 2021;93(10):6063–7.
Park S, Michelow IC, Choe YJ. Shifting Patterns of Respiratory Virus Activity Following Social Distancing Measures for Coronavirus Disease 2019 in South Korea [J]. J Infect Dis. 2021;224(11):1900–6.
Prevention UCFDCA. NCIRD overview of influenza surveillance in the United States [Z]. 2018.
Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology [J]. Clin Microbiol Rev. 2010;23(1):74–98.
Aktürk H, SüTçü M, Badur S, Törün SH, Çitak A, Erol OB, Somer A, Salman N. Evaluation of epidemiological and clinical features of influenza and other respiratory viruses [J]. Turk Pediatr Arsivi. 2015;50(4):217–25.
Zhong P, Zhang H, Chen X, Lv F. Clinical characteristics of the lower respiratory tract infection caused by a single infection or coinfection of the human parainfluenza virus in children [J]. J Med Virol. 2019;91(9):1625–32.
Kim HM, Lee EJ, Lee NJ, Woo SH, Kim JM, Rhee JE, Kim EJ. Impact of coronavirus disease 2019 on respiratory surveillance and explanation of high detection rate of human rhinovirus during the pandemic in the Republic of Korea [J]. Influenza Other Respir Viruses. 2021;15(6):721–31.
Chen AP, Chu IY, Yeh ML, Chen YY, Lee CL, Lin HH, Chan YJ, Chen HP. Differentiating impacts of non-pharmaceutical interventions on non-coronavirus disease-2019 respiratory viral infections: Hospital-based retrospective observational study in Taiwan [J]. Influenza Other Respir Viruses. 2021;15(4):478–87.
Li L, Wang H, Liu A, Wang R, Zhi T, Zheng Y, Bao Y, Chen Y, Wang W. Comparison of 11 respiratory pathogens among hospitalized children before and during the COVID-19 epidemic in Shenzhen, China [J]. Virol J. 2021;18(1):202.
Kume Y, Hashimoto K, Chishiki M, Norito S, Suwa R, Ono T, Mochizuki I, Mashiyama F, Ishibashi N, Suzuki S, et al. Changes in virus detection in hospitalized children before and after the severe acute respiratory syndrome coronavirus 2 pandemic [J]. Influenza Other Respir Viruses. 2022;16(5):837–41.
L’Huillier AG, Tapparel C, Turin L, Boquete-Suter P, Thomas Y, Kaiser L. Survival of rhinoviruses on human fingers [J]. Clin Microbiol Infect. 2015;21(4):381–5.
Zhang RX, Chen DM, Qian Y, Sun Y, Zhu RN, Wang F, Ding YX, Guo Q, Zhou YT, Qu D, et al. Surges of hospital-based rhinovirus infection during the 2020 coronavirus disease-19 (COVID-19) pandemic in Beijing, China [J]. World J Pediatr: WJP. 2021;17(6):590–6.
Leung NHL, Chu DKW, Shiu EYC, Chan KH, McDevitt JJ, Hau BJP, Yen HL, Li Y, Ip DKM, Peiris JSM, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks [J]. Nat Med. 2020;26(5):676–80.
Liu P, Xu M, Lu L, Ma A, Cao L, Su L, Dong N, Jia R, Zhu X, Xu J. The changing pattern of common respiratory and enteric viruses among outpatient children in Shanghai, China: Two years of the COVID-19 pandemic [J]. J Med Virol. 2022;94(10):4696–703.
Bosco A. Emerging role for interferons in respiratory viral infections and childhood asthma [J]. Front Immunol. 2023;14:1109001.
Harless J, Ramaiah R, Bhananker SM. Pediatric airway management [J]. Int J Crit Illn Inj Sci. 2014;4(1):65–70.
Wang H, Zheng Y, Deng J, Wang W, Liu P, Yang F, Jiang H. Prevalence of respiratory viruses among children hospitalized from respiratory infections in Shenzhen, China [J]. Virol J. 2016;13:39.
Zhang D, He Z, Xu L, Zhu X, Wu J, Wen W, Zheng Y, Deng Y, Chen J, Hu Y, et al. Epidemiology characteristics of respiratory viruses found in children and adults with respiratory tract infections in southern China [J]. IJID. 2014;25:159–64.
Acknowledgements
The authors thank all the hospital personnel who performed the electronic medical records, the laboratory staff involved in performing the analysis of the virus tests, and the Henan Provincial Health and Wellness Committee for their support of this work.
Funding
This work was funded by Medical Science and Technology Projects of Henan Province (LHGJ20190958 and LHGJ20210629).
Author information
Authors and Affiliations
Contributions
HY: conceived the study, designed statistical and modelling methods, conducted analyses, interpreted results, wrote and revised the manuscript, and funding support; BZ: data curation, analysis and visualization, and manuscript revision; FY: data collection, curation, and visualization; PGW: data collection; YZ: conceptualization, conceived the study, statistical analyses, manuscript revision, and funding support. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors of this article have no conflicts of interest or any direct or indirect financial interests.
Ethical Approval and Consent to Participate
The study was approved by the Ethics Committee of Children's Hospital Affiliated to Zhengzhou University. This retrospective study did not involve any personal private information of the patients and only statistical analysis of the available test data was performed. The committee waived the need for individual informed consent.
Consent for Publication
This was a retrospective study, no consent needed. All co-authors declare that the work described is original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. All the authors listed have approved the manuscript to be published.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yan, H., Zhai, B., Yang, F. et al. The Impact of Non-pharmacological Interventions Measures Against COVID-19 on Respiratory Virus in Preschool Children in Henan, China. J Epidemiol Glob Health 14, 54–62 (2024). https://doi.org/10.1007/s44197-023-00168-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s44197-023-00168-3